Matches in SemOpenAlex for { <https://semopenalex.org/work/W2766453463> ?p ?o ?g. }
- W2766453463 endingPage "202" @default.
- W2766453463 startingPage "193" @default.
- W2766453463 abstract "•The effects of bariatric surgery on lipid profile in obese patients were evaluated. •Bariatric surgery has favorable effects on triglycerides, low-density lipoprotein cholesterol, and apolipoprotein (apo) B. •Surgery also increases high-density lipoprotein cholesterol and apoA1 and reduces apoB/apoA1 ratio and SAA1/PON1 ratio. •No changes in macrophage cholesterol efflux capacity was observed. Background Bariatric surgery has been shown to reduce cardiovascular events and cause-specific mortality for coronary artery disease in obese patients. Lipoprotein biomarkers relating to low-density lipoprotein (LDL), high-density lipoprotein (HDL), their subfractions, and macrophage cholesterol efflux have all been hypothesized to be of value in cardiovascular risk assessment. Objectives The objective of this study was to examine the effect of a lifestyle intervention followed by bariatric surgery on the lipid profile of morbidly obese patients. Methods Thirty-four morbidly obese patients were evaluated before and after lifestyle changes and then 1 year after bariatric surgery. They were compared with 17 lean subjects. Several lipoprotein metrics, serum amyloid A (SAA), serum paraoxonase-1 (PON1), and macrophage cholesterol efflux capacity (CEC) were assessed. Results Average weight loss after the lifestyle intervention was 10.5% and 1 year after bariatric surgery was 33.9%. The lifestyle intervention significantly decreased triglycerides (TGs; −28.7 mg/dL, P < .05), LDL cholesterol (LDL-C; −32.3 mg/dL, P < .0001), and apolipoprotein B (apoB; −62.9 μg/mL, P < .001). Bariatric surgery further reduced TGs (−36.7 mg/dL, P < .05), increased HDL cholesterol (+12 mg/dL, P < .0001), and reductions in LDL-C and apoB were sustained. Bariatric surgery reduced large, buoyant LDL (P < .0001), but had no effect on the small, dense LDL. The large HDL subfractions increased (P < .0001), but there was no effect on the smaller HDL subfractions. The ratio for SAA/PON1 was reduced after the lifestyle intervention (P < .01) and further reduced after bariatric surgery (P < .0001). Neither the lifestyle intervention nor bariatric surgery had any effect on CEC. Conclusions Lifestyle intervention followed by bariatric surgery in 34 morbidly obese patients showed favorable effects on TGs, LDL-C, and apoB. HDL cholesterol and apoA1 was increased, apoB/apoA1 ratio as well as SAA/PON1 ratio reduced, but bariatric surgery did not influence CEC. Bariatric surgery has been shown to reduce cardiovascular events and cause-specific mortality for coronary artery disease in obese patients. Lipoprotein biomarkers relating to low-density lipoprotein (LDL), high-density lipoprotein (HDL), their subfractions, and macrophage cholesterol efflux have all been hypothesized to be of value in cardiovascular risk assessment. The objective of this study was to examine the effect of a lifestyle intervention followed by bariatric surgery on the lipid profile of morbidly obese patients. Thirty-four morbidly obese patients were evaluated before and after lifestyle changes and then 1 year after bariatric surgery. They were compared with 17 lean subjects. Several lipoprotein metrics, serum amyloid A (SAA), serum paraoxonase-1 (PON1), and macrophage cholesterol efflux capacity (CEC) were assessed. Average weight loss after the lifestyle intervention was 10.5% and 1 year after bariatric surgery was 33.9%. The lifestyle intervention significantly decreased triglycerides (TGs; −28.7 mg/dL, P < .05), LDL cholesterol (LDL-C; −32.3 mg/dL, P < .0001), and apolipoprotein B (apoB; −62.9 μg/mL, P < .001). Bariatric surgery further reduced TGs (−36.7 mg/dL, P < .05), increased HDL cholesterol (+12 mg/dL, P < .0001), and reductions in LDL-C and apoB were sustained. Bariatric surgery reduced large, buoyant LDL (P < .0001), but had no effect on the small, dense LDL. The large HDL subfractions increased (P < .0001), but there was no effect on the smaller HDL subfractions. The ratio for SAA/PON1 was reduced after the lifestyle intervention (P < .01) and further reduced after bariatric surgery (P < .0001). Neither the lifestyle intervention nor bariatric surgery had any effect on CEC. Lifestyle intervention followed by bariatric surgery in 34 morbidly obese patients showed favorable effects on TGs, LDL-C, and apoB. HDL cholesterol and apoA1 was increased, apoB/apoA1 ratio as well as SAA/PON1 ratio reduced, but bariatric surgery did not influence CEC." @default.
- W2766453463 created "2017-11-10" @default.
- W2766453463 creator A5008473720 @default.
- W2766453463 creator A5022766917 @default.
- W2766453463 creator A5025145430 @default.
- W2766453463 creator A5029307490 @default.
- W2766453463 creator A5053113530 @default.
- W2766453463 creator A5053240117 @default.
- W2766453463 creator A5058571312 @default.
- W2766453463 creator A5089644471 @default.
- W2766453463 creator A5091832049 @default.
- W2766453463 date "2018-01-01" @default.
- W2766453463 modified "2023-10-16" @default.
- W2766453463 title "Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity" @default.
- W2766453463 cites W1860149084 @default.
- W2766453463 cites W1869060308 @default.
- W2766453463 cites W1964018654 @default.
- W2766453463 cites W1964997738 @default.
- W2766453463 cites W1979378269 @default.
- W2766453463 cites W1981123659 @default.
- W2766453463 cites W1987593352 @default.
- W2766453463 cites W1988565488 @default.
- W2766453463 cites W1991398238 @default.
- W2766453463 cites W1992545920 @default.
- W2766453463 cites W2007490518 @default.
- W2766453463 cites W2014345388 @default.
- W2766453463 cites W2028943130 @default.
- W2766453463 cites W2036157542 @default.
- W2766453463 cites W2036260862 @default.
- W2766453463 cites W2054236766 @default.
- W2766453463 cites W2058652637 @default.
- W2766453463 cites W2059654328 @default.
- W2766453463 cites W2071463140 @default.
- W2766453463 cites W2083177676 @default.
- W2766453463 cites W2092475995 @default.
- W2766453463 cites W2092536443 @default.
- W2766453463 cites W2095880708 @default.
- W2766453463 cites W2097174145 @default.
- W2766453463 cites W2098824324 @default.
- W2766453463 cites W2109429564 @default.
- W2766453463 cites W2116775019 @default.
- W2766453463 cites W2119092533 @default.
- W2766453463 cites W2121076428 @default.
- W2766453463 cites W2145813488 @default.
- W2766453463 cites W2146520216 @default.
- W2766453463 cites W2149203958 @default.
- W2766453463 cites W2153292820 @default.
- W2766453463 cites W2155168556 @default.
- W2766453463 cites W2158916086 @default.
- W2766453463 cites W2163131341 @default.
- W2766453463 cites W2169664803 @default.
- W2766453463 cites W2288425629 @default.
- W2766453463 cites W2315957563 @default.
- W2766453463 cites W2367435011 @default.
- W2766453463 cites W2411994780 @default.
- W2766453463 cites W2537802215 @default.
- W2766453463 cites W3187443279 @default.
- W2766453463 cites W36419898 @default.
- W2766453463 cites W4240345859 @default.
- W2766453463 cites W4250939030 @default.
- W2766453463 doi "https://doi.org/10.1016/j.jacl.2017.10.007" @default.
- W2766453463 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29146227" @default.
- W2766453463 hasPublicationYear "2018" @default.
- W2766453463 type Work @default.
- W2766453463 sameAs 2766453463 @default.
- W2766453463 citedByCount "28" @default.
- W2766453463 countsByYear W27664534632018 @default.
- W2766453463 countsByYear W27664534632019 @default.
- W2766453463 countsByYear W27664534632020 @default.
- W2766453463 countsByYear W27664534632021 @default.
- W2766453463 countsByYear W27664534632022 @default.
- W2766453463 countsByYear W27664534632023 @default.
- W2766453463 crossrefType "journal-article" @default.
- W2766453463 hasAuthorship W2766453463A5008473720 @default.
- W2766453463 hasAuthorship W2766453463A5022766917 @default.
- W2766453463 hasAuthorship W2766453463A5025145430 @default.
- W2766453463 hasAuthorship W2766453463A5029307490 @default.
- W2766453463 hasAuthorship W2766453463A5053113530 @default.
- W2766453463 hasAuthorship W2766453463A5053240117 @default.
- W2766453463 hasAuthorship W2766453463A5058571312 @default.
- W2766453463 hasAuthorship W2766453463A5089644471 @default.
- W2766453463 hasAuthorship W2766453463A5091832049 @default.
- W2766453463 hasBestOaLocation W27664534632 @default.
- W2766453463 hasConcept C104317684 @default.
- W2766453463 hasConcept C126322002 @default.
- W2766453463 hasConcept C134018914 @default.
- W2766453463 hasConcept C135763542 @default.
- W2766453463 hasConcept C141071460 @default.
- W2766453463 hasConcept C2778163477 @default.
- W2766453463 hasConcept C2778270857 @default.
- W2766453463 hasConcept C2780072125 @default.
- W2766453463 hasConcept C2780541478 @default.
- W2766453463 hasConcept C2780745583 @default.
- W2766453463 hasConcept C37501387 @default.
- W2766453463 hasConcept C511355011 @default.
- W2766453463 hasConcept C544821477 @default.
- W2766453463 hasConcept C55493867 @default.
- W2766453463 hasConcept C62746215 @default.